Novel therapy could cut hepatitis C prevalence by 80 percent
Recently approved antiviral medications for hepatitis C could reduce the prevalence of the blood-borne infection by more than 80 percent, researchers have estimated.
Dec 02, 2015, 11:33 AM IST